A bill to amend the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Email me when S 5812 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 5812. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill amends the Federal Food, Drug, and Cosmetic Act so the Secretary of Health and Human Services can continue awarding priority review vouchers for medicines that treat rare pediatric diseases without a time limit. This gives drug makers a lasting incentive to develop such treatments, which could expand options for children with uncommon conditions. By extending the program permanently, the measure seeks to boost research and development in this underserved area.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 5812
3 free questions a day, no accountSponsors
- Sen. Moody, Ashley [R-FL] (R) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 5812 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 5812 freeOr ask your AI assistant about S 5812 directly:
Add to Claude, ChatGPT or Cursor